
Cafnea™ Oral Solution
Cafnea oral solution contains caffeine base 12.5mg, citric acid monohydrate and sodium citrate in water for injections to 5mL. Caffeine base 12.5mg is equivalent to caffeine citrate 25mg.
Cafnea Oral Solution is indicated for the short-term treatment of apnoea of prematurity in infants of gestational age 28 to less than 33 weeks.
Strength25mg caffeine citrate in 5mL, equivalent to 12.5mg caffeine base in 5mL |
Package5mL solution in 7mL vial |
Pack Size10 vials |
Phebra CodeSOL026 |
Please log in to place an order
Product Information
Consumer Medicine Information
Material Safety Data Sheet
